IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial NCT04628338 · COMPLETED

Trial details

NCT number: NCT04628338
Sponsor: Sawa Ito, MD
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Myeloid Leukemia Allogeneic Stem Cell Transplantation

Start date: 2021-03-08
Primary completion: 2023-10-30
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.